Schedule 13D ownership disclosure
Sucampo Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 864909106
Event date: 2017-09-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-297879
- Form type
- SC 13D
- Filer
- Sucampo Pharmaceuticals, Inc.
- CIK
- CIK 1365216
- Filed
- Sep 28, 2017
- Reporting period
- Sep 11, 2017
- Description
- Schedule 13D beneficial ownership